SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy

  1. Bamias, A.
  2. Merseburger, A.S.
  3. Loriot, Y.
  4. James, N.
  5. Choy, E.
  6. Castellano, D.
  7. Lopez-Rios, F.
  8. Calabrò, F.
  9. Kramer, M.
  10. de Velasco, G.
  11. Zakopoulou, R.
  12. Tzannis, K.
  13. Sternberg, C.N.
Aldizkaria:
ESMO open

ISSN: 2059-7029

Argitalpen urtea: 2021

Alea: 6

Zenbakia: 3

Orrialdeak: 100152

Mota: Artikulua

DOI: 10.1016/J.ESMOOP.2021.100152 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus